CNBX Pharmaceuticals Inc. (CNBX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2005: -$1.3K2006: $144.4K2007: $317.3K2008: $289.9K2009: $174.9K2010: $60.0K2011: -$47.3K2012: -$49.0K2013: -$105.4K2014: $40.1K2015: -$309.6K2016: -$467.4K2017: -$2.94M2018: $2.65M2019: $14.74M2020: $1.76M2021: $1.81M2022: $1.63M2023: -$2.02M2024: -$2.48M2025: -$2.50M-$2.50M
2005Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$2.50M-0.7%
2024-$2.48M-22.9%
2023-$2.02M-223.6%
2022$1.63M-9.6%
2021$1.81M+2.3%
2020$1.76M-88.0%
2019$14.74M+457.3%
2018$2.65M+190.0%
2017-$2.94M-528.7%
2016-$467.4K-51.0%
2015-$309.6K-872.5%
2014$40.1K+138.0%
2013-$105.4K-115.1%
2012-$49.0K-3.5%
2011-$47.3K-178.9%
2010$60.0K-65.7%
2009$174.9K-39.6%
2008$289.9K-8.7%
2007$317.3K+119.7%
2006$144.4K+11394.0%
2005-$1.3K